LeanDose review
Both published figures are labeled first-month prices, and no ongoing rate appears anywhere.
The verdict
LeanDose publishes first-month prices from $159 for semaglutide and $279 for tirzepatide, read August 2026. Both are labeled as first-month figures. No ongoing monthly rate is published on the site or in the intake.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $159/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
LeanDose sells both molecules by injection and describes its pricing as transparent first-month all-inclusive. It states the medication is prepared by an FDA-registered compounding pharmacy.
Who writes the prescription, and what do they see?
The pages name the pharmacy's registration status rather than the clinician. Registration is a real fact about a facility and it is not a statement about who writes the prescription or what they review.
The seller uses the word transparent and applies it to one month. Its own copy adds that the ongoing monthly cost may differ, which is an honest sentence and the only thing said about month two. A reader cannot get further than that without starting.
What happens when the dose goes up?
Nothing is published about dose. Since the ongoing rate is also unpublished, both variables that decide a year's cost are unavailable before signing up. That is a rarer gap than an unstated dose alone.
What the price includes
$159 buys a first month and nothing establishes the second. Six months cannot be computed from anything on the site. Treat both figures as introductory and ask for the ongoing rate in writing before ordering.
What it claims, and what it cites
Both lines are compounded. An FDA-registered compounding pharmacy is stated to prepare them. Registration is not FDA review of the preparation, which does not happen before dispensing.
Where it holds up, and where it does not
- Strength: A registered compounding pharmacy is named as such
- Strength: The first-month label is explicit
- Strength: The seller states the ongoing cost may differ
- Limitation: No ongoing rate is published anywhere
- Limitation: The intake does not reveal it either
- Limitation: No milligram dose stated
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about LeanDose. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will get the month-two rate in writing before the first charge.
- Wrong for
- A reader who needs to price six months before starting.
How LeanDose compares
| Seller | Who it suits | Go |
|---|---|---|
 Lumora | Readers willing to complete an assessment and hold the seller to its own promise | See Lumora → |
 MANÜ Telehealth | Readers who want the cost of a full dose stated before starting a low one | See MANÜ Telehealth → |
 Levers Health | Readers comfortable paying in two-month blocks who want a low-dose tier | See Levers Health → |
More GLP-1 telehealth sellers reviews: Ozari HealthPallas HealthPepHaūsPeterMDPlexusDxPlushCare
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What does month two cost?
- LeanDose does not publish it. Both figures are labeled first-month prices and the site states the ongoing monthly cost may differ.
- Does FDA-registered mean FDA-approved?
- No. Registration describes the facility. The FDA does not review a compounded preparation before it is dispensed.
- Can I find the ongoing rate in the intake?
- It does not appear there either, which is why it has to be asked for directly.